FDA warning letters
A warning letter is FDA's formal notice that a company broke the law, usually found during an inspection. The company has 15 working days to reply. Letters that go unanswered lead to seizures, import bans or court orders.
1,276 letters match. Newest first.
-
DrugsImprimisRx NJ
FDA found insanitary sterile compounding and subpotent timolol-latanoprost eye drops at ImprimisRx NJ.
High risk -
DrugsRemedyRepack, Inc.
RemedyRepack, a drug repackager in Indiana, Pennsylvania, failed CGMP, including cleaning and beta-lactam cross-contamination controls.
High risk -
Drugscitypharma.us
FDA warned citypharma.us for selling unapproved, misbranded opioid, benzodiazepine, and stimulant drugs to U.S. consumers online.
High risk -
DrugsNew England Life Care, Inc. dba Advanced Compounding Solutions
FDA cites Advanced Compounding Solutions for insanitary sterile-drug production and CGMP failures after a 2022 inspection.
High risk -
DrugsChampaklal Maganlal Homeo Pharmacy Private Limited
FDA says Champaklal Maganlal Homeo Pharmacy's Bebelyn diarrhea and colic products are unapproved new drugs for infants.
High risk -
DrugsSure-Biochem Laboratories, LLC
FDA says contract lab Sure-Biochem missed Burkholderia cepacia in drug samples and cites broad CGMP failures.
High risk -
DrugsiSlim, LLC
FDA warned iSlim, LLC that its Alfia Weight Loss Capsules are an unapproved, misbranded drug containing undeclared sibutramine.
High risk -
DrugsPharmedica USA, LLC
FDA found Pharmedica made ophthalmic and nasal drugs under insanitary conditions without required sterile controls.
High risk -
DrugsSorcerz.com
FDA warned Sorcerz.com for selling unapproved, misbranded opioid and benzodiazepine drugs to U.S. consumers online.
High risk -
DrugsDrivergent, Inc.
Drivergent's hand sanitizers had acetaldehyde and acetal above allowed limits, FDA says.
High risk -
DrugsPremier Nutra Pharma Inc.
FDA cited Premier Nutra Pharma, a Carlsbad, California contract maker of nasal spray drugs, for CGMP violations after microbial contamination.
High risk -
DrugsTager Online, Inc. DBA Volt Candy; Volt Candy Wholesale Club
FDA warned Volt Candy that PrimeZEN Black 6000, sold as a supplement, contained undeclared tadalafil and sildenafil and was an unapproved, misbranded drug.
High risk -
DrugsNose Slap LLC
FDA told Nose Slap LLC its NOSE SLAP and SOUL SLAP smelling-salt stimulants are unapproved and misbranded drugs.
High risk -
DrugsAccra-Pac, Inc. dba Voyant Beauty
Voyant Beauty's Elkhart, Indiana plant made OTC aerosol drugs contaminated with benzene and failed to investigate or test properly.
High risk -
DrugsMedolife Rx D/B/A MedoLife Corp., AELIA, Inc. and Quanta Inc.
FDA says Medolife sold unapproved Escozine drugs online with claims to treat cancer, HIV, and COVID-19.
High risk -
DrugsPharmaplast S.A.E.
FDA cited Pharmaplast S.A.E. for failing to test drug components, including glycerin and ethanol, for dangerous contaminants.
High risk -
DrugsZermat International S.A. de C.V.
FDA warns Zermat International about current good manufacturing practice violations for OTC drugs, including releasing out-of-specification lots without investigation.
High risk -
DrugsChemical Services Group, Inc./Royal Chemical Company
Royal Chemical Company made OTC hand sanitizer on equipment shared with industrial chemicals, and FDA found cleaning, supplier testing and quality unit failures.
High risk -
DrugsBelmar Pharma Solutions, Drug Depot, LLC., dba APS Pharmacy
FDA warns Drug Depot dba APS Pharmacy over compounded drugs made with ineligible bulk substances.
Medium -
DrugsEco Lips, Inc.
FDA warned Eco Lips, Inc. that its over-the-counter sunscreen drug products had serious manufacturing and testing failures.
High risk -
DrugsChampaklal Maganlal Homeo Pharmacy Private Limited
Champaklal Maganlal Homeo Pharmacy failed to test each glycerin lot for identity, including DEG/EG, in OTC and homeopathic drugs.
High risk -
DrugsOmega Packaging Corp
Omega Packaging Corp failed to test hand sanitizer ingredients and validate processes, FDA found.
High risk -
DrugsTyrone L. McCall, M.D./Cornea Associates of Texas
FDA warns Dallas eye practice Cornea Associates for running a 69-subject drug study without an IND.
High risk -
DrugsRobert J. Hayashi, M.D./Washington University School of Medicine, Department of Pediatrics
FDA warned Dr. Robert J. Hayashi over protocol deviations in pediatric drug trials that exposed a child to unnecessary study drug and invasive procedures.
High risk -
DrugsNuGeneration Technologies LLC
FDA inspected NuGeneration Technologies' Emeryville, California drug plant and found CGMP failures in hand sanitizer release testing, ingredient and water testing, stability and process validation.
High risk -
Drugswww.ivermectin4covid.com
FDA warned website ivermectin4covid.com for selling unapproved, misbranded ivermectin drugs claiming COVID-19 use.
High risk -
DrugsProcter & Gamble Manufactura S. de R.L. de C.V.
FDA warned P&G Manufactura over mismatched active ingredients in the drug listing for Vicks Nyquil Severe Hot Remedy.
Low -
DrugsCosmetic Science Laboratories LLC
FDA warned Cosmetic Science Laboratories about OTC sunscreen drugs made without required manufacturing controls.
High risk -
DrugsDunagin Pharmaceuticals Inc. dba Massco Dental
Dunagin Pharmaceuticals dba Massco Dental made oral drugs with CGMP violations including shared equipment and inadequate component testing.
High risk -
DrugsMaggie Jeffries, M.D. / Avanti Anesthesiology, LLC
FDA warns Houston clinical investigator Dr. Maggie Jeffries for running drug trials without an IND and with informed-consent failures.
High risk -
DrugsElectRx and Health Solutions, LLC
ElectRx causes introduction of unapproved and misbranded prescription drugs into interstate commerce by substituting foreign-sourced drugs for FDA-approved prescriptions.
High risk -
DrugsFormology Lab Inc.
FDA warned Formology Lab Inc. about manufacturing rule violations for drugs, including untested ingredients and unvalidated sunscreen processes.
High risk -
DrugsMidlab Incorporated
FDA cited Midlab in Athens, Tennessee for manufacturing violations and unapproved, misbranded hand sanitizer and antibacterial soap drugs.
High risk -
DrugsFrenda Corporation
FDA found Frenda made OTC alcohol and hand sanitizer under insanitary conditions with industrial chemical cross-contamination risk.
High risk -
DrugsProfounda, Inc.
FDA warns Profounda about manufacturing quality failures for over-the-counter drugs, including process validation, stability, water system, and glycerin testing.
High risk -
DrugsAtlantic Management Resources LTD dba. Claire Ellen Products
Atlantic Management Resources (Claire Ellen Products) had CGMP violations and distributed unlisted Neuroquell Plus Cream.
Medium -
DrugsB & J Group
B & J Group, a Morrisville, PA contract filler of OTC hand sanitizer, was cited by FDA for skipping finished-product and ingredient testing.
High risk -
DrugsGascó Industrial Corporation
FDA cites Gascó Industrial for CGMP violations in OTC hand soap, antiseptics, and hand sanitizer, including shared equipment with industrial products.
High risk -
DrugsSkyless, LLC
FDA cited Skyless, LLC for CGMP failures and for selling three X-PASMO topical analgesic ointments as unapproved and misbranded drugs.
High risk -
DrugsUltra Chem Labs Corporation
FDA warns Ultra Chem Labs about methanol-tainted hand sanitizer sold as an unapproved, misbranded drug.
High risk -
DrugsDelta Kozmetik Sanayi Ve Ticaret-Selim Yesil
FDA warned Delta Kozmetik that its OTC drug products were adulterated due to CGMP violations.
High risk -
DrugsClean Cosmetics LLC
FDA warned Clean Cosmetics LLC over manufacturing failures in OTC hand sanitizer, including ethanol contaminated with methanol.
High risk -
DrugsThe Body Bean, LLC
FDA warns The Body Bean over unregistered, unlisted scented hand sanitizer for U.S. sale.
Low -
DrugsSalon Technologies International, Inc.
FDA warns Salon Technologies International that its hand sanitizers contained unacceptable acetaldehyde, acetal and benzene impurities and were adulterated.
High risk -
DrugsQuality Supplement Manufacturing, Inc.
FDA cited Quality Supplement Manufacturing for dietary supplement manufacturing and labeling violations, including undeclared shellfish allergens.
High risk -
DrugsNoble Elements, LLC
FDA warns Noble Elements over unapproved, misbranded Coated Silver drug claims on its website.
High risk -
DrugsOrganic Heirloom Plants
FDA warned Organic Heirloom Plants over selling unapproved drugs with claims to treat mpox, cancer, diabetes and other diseases.
High risk -
DrugsDr. Green Mom, LLC
FDA warned Dr. Green Mom, LLC that its vitamin, zinc, immunity and colloidal silver products are unapproved new drugs because of disease claims on its website.
High risk -
DrugsOld Tiles Wallpaper, LLC DBA Old Tiles Decor
Old Tiles Decor sold three unapproved 'Wind River' remedies online with drug claims, including treating mpox sores, heart problems and flu.
High risk -
DrugsMonkeypox-treatment.com
FDA warned Monkeypox-treatment.com and Eric Sminia for promoting Amazon-linked products as mpox treatments without FDA approval.
High risk